/PRNewswire/ Fzata, Inc., announces that it has been selected to present its first-in-class Bioengineered Probiotic Yeast Medicines (BioPYM™) platform at.
Fzata to Pitch BioPYM™ Platform at the Biotech Showcase™ 2023 prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.